Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Apr;45(4):582–587. doi: 10.1038/bjc.1982.95

Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.

C Clarke, K B Dawson, P W Sheldon
PMCID: PMC2010990  PMID: 7073948

Abstract

A quantitative, cytochemical assay for measuring lysosomal enzymes in the peripheral nerves of mice has been developed. That the time course of lysosomal enzyme changes after misonidazole (MISO) treatment reflects the degree of neurotoxicity of this agent in the mouse, has been confirmed by the use of two known neurotoxic compounds: methyl mercury and acrylamide. This effect is specific to the peripheral nerves and was not found in liver, kidney, heart or cerebral cortex. Enzyme activities varied with mouse strain and sex, as did the response to MISO treatment. Of the mice studied, female C57 gave the greatest increase in beta-glucuronidase activity. With the MISO dose of 0.6 mg/g/dose the increased enzyme activity was independent of the route of administration and appeared to approach a plateau after 5 daily doses.

Full text

PDF
582

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams G. E. Hypoxic cell sensitizers for radiotherapy. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):135–141. doi: 10.1016/0360-3016(78)90129-3. [DOI] [PubMed] [Google Scholar]
  2. Brown J. M., Yu N. Y., Cory M. J., Bicknell R. B., Taylor D. L. In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs. Br J Cancer Suppl. 1978 Jun;3:206–211. [PMC free article] [PubMed] [Google Scholar]
  3. Cavanagh J. B. Peripheral neuropathy caused by chemical agents. CRC Crit Rev Toxicol. 1973 Nov;2(3):365–417. doi: 10.3109/10408447309082021. [DOI] [PubMed] [Google Scholar]
  4. Conroy P. J., Von Burg R., Passalacqua W., Penney D. P., Sutherland R. M. Misonidazole neurotoxicity in the mouse: evaluation of functional, pharmacokinetic, electrophysiologic and morphologic parameters. Int J Radiat Oncol Biol Phys. 1979 Jul;5(7):983–991. doi: 10.1016/0360-3016(79)90604-7. [DOI] [PubMed] [Google Scholar]
  5. Disch S., Saunders M. I., Anderson P., Urtasun R. C., Karcher K. H., Kogelnik H. D., Bleehen N., Phillips T. L., Wasserman T. H. The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol. 1978 Dec;51(612):1023–1024. doi: 10.1259/0007-1285-51-612-1023. [DOI] [PubMed] [Google Scholar]
  6. Hirst D. G., Vojnovic B., Hobson B. Changes in nerve conduction velocity in the mouse after acute and chronic administration of nitroimidazoles. Br J Cancer. 1979 Feb;39(2):159–167. doi: 10.1038/bjc.1979.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hirst D. G., Vojnovic B., Stratford I. J., Travis E. L. The effect of the radiosensitizer misonidazole on motor nerve conduction velocity in the mouse. Br J Cancer Suppl. 1978 Jun;3:237–241. [PMC free article] [PubMed] [Google Scholar]
  8. Rose G. P., Dewar A. J., Stratford I. J. A biochemical method for assessing the neurotoxic effects of misonidazole in the rat. Br J Cancer. 1980 Dec;42(6):890–899. doi: 10.1038/bjc.1980.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Saunders M. E., Dische S., Anderson P., Flockhart I. R. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum. Br J Cancer Suppl. 1978 Jun;3:268–270. [PMC free article] [PubMed] [Google Scholar]
  10. Von Burg R., Conroy P. J., Passalacqua W. Peripheral electrophysiological parameters in mice treated with misonidazole. Br J Cancer. 1979 Jul;40(1):134–143. doi: 10.1038/bjc.1979.149. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES